SAND - Clinical trial • Breast Cancer Foundation NZ


Early Breast Cancer clinical trials for ER+

Updated: January 20, 2022

This study aims to reduce inflammation in post-menopausal women with breast cancer through the use of asprin.

Previous work suggests that the presence of inflammation in post-menopausal breast cancer is associated with a poor response to aromatase inhibitor treatment. Here, an anti-inflammatory drug aspirin is given with the aromatase inhibitor, and the breast cancer will be sampled before and after the treatment, given in the window of time between diagnosis and definitive surgery.

Key inclusion criteria

  • ER positive, stage 1-2 breast cancer, post-menopausal, no prior therapy
  • Minimum age: 50 Years

Key exclusion criteria

  • not post-menopausal, prior breast cancer, other illnesses

    Full trial information

    New Zealand



    Bridget Robinson

    If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.

    Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at

    Similar clinical trials

    For Early Breast Cancer , Supportive Care

    Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to

    Find clinical trials

    Interested in a clinical trial?

    Subscribe for updates & stay in the loop with new studies.